Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006497 |
---|---|
Receipt number | R000007605 |
Scientific Title | A phase II trial of sequential treatment from cisplatin-etoposide therapy (PE) to irinotecan hydrochloride + amrubicin hydrochloride therapy with concomitant use of G-CSF nartograstim in patients with extensive-stage small cell lung cancer or advanced large cell neuroendocrine carcinoma (LCNEC) |
Date of disclosure of the study information | 2011/10/07 |
Last modified on | 2011/10/05 21:04:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/10/06 20:40:37 |